scholarly journals Lyme Disease Surveillance in England and Wales, 1986-1998

2000 ◽  
Vol 6 (4) ◽  
pp. 404-407 ◽  
Author(s):  
Robert Smith
2003 ◽  
Vol 7 (48) ◽  
Author(s):  
◽  

The Health Protection Agency Communicable Disease Surveillance Centre for England and Wales and others have reported that the number of people living with HIV in the UK has increased


2016 ◽  
Vol 65 (2) ◽  
pp. 266-274 ◽  
Author(s):  
J. Bjork ◽  
C. Brown ◽  
H. Friedlander ◽  
E. Schiffman ◽  
D. Neitzel

2001 ◽  
Vol 126 (3) ◽  
pp. 397-414 ◽  
Author(s):  
T. L. LAMAGNI ◽  
B. G. EVANS ◽  
M. SHIGEMATSU ◽  
E. M. JOHNSON

Invasive fungal infections are becoming an increasing public health problem owing to the growth in numbers of susceptible individuals. Despite this, the profile of mycoses remains low and there is no surveillance system specific to fungal infections currently existing in England and Wales. We analysed laboratory reports of deep-seated mycoses made to the Communicable Disease Surveillance Centre between 1990 and 1999 from England and Wales. A substantial rise in candidosis was seen during this period (6·76–13·70 reports per million population/year), particularly in the older age groups. Rates of cryptococcosis in males fluctuated over the decade but fell overall (1·05–0·66 per million population/year), whereas rates of female cases gradually rose up until 1998 (0·04–0·41 per million population/year). Reports of Pneumocystis carinii in men reduced substantially between 1990 and 1999 (2·77–0·42 per million population/year) but showed little change in women. Reports of aspergillosis fluctuated up until 1996, after which reports of male and female cases rose substantially (from 0·08 for both in 1996 to 1·92 and 1·69 per million population/year in 1999 for males and females respectively), largely accounted for by changes in reporting practice from one laboratory. Rates of invasive mycoses were generally higher in males than females, with overall male-to-female rate ratios of 1·32 (95% CI 1·25–1·40) for candidosis, 1·30 (95% CI 1·05–1·60) for aspergillosis, 3·99 (95% CI 2·93–5·53) for cryptococcosis and 4·36 (95% CI 3·47–5·53) for Pneumocystis carinii. The higher male than female rates of reports is likely to be a partial reflection of HIV epidemiology in England and Wales, although this does not fully explain the ratio in infants and older age groups. Lack of information on underlying predisposition prevents further identification of risk groups affected. Whilst substantial under-reporting of Pneumocystis carinii and Cryptococcus species was apparent, considerable numbers of superficial mycoses were mis-reported indicating a need for clarification of reporting guidelines. Efforts to enhance comprehensive laboratory reporting should be undertaken to maximize the utility of this approach for surveillance of deep-seated fungal infections.


1991 ◽  
Vol 2 (2) ◽  
pp. 58-60
Author(s):  
Dennis J White

Investigation of the epidemiology of Lyme disease depends upon information generated from several sources. Human disease surveillance can be conducted by both passive and active means involving physicians, public health agencies and laboratories. Passive and active tick surveillance programs can document the extent of tick-borne activity, identify the geographic range of potential vector species, and determine the relative risk of exposure to Lyme disease in specific areas. Standardized laboratory services can play an important role in providing data. Epidemiologists can gain a better understanding of Lyme disease through the collection of data from such programs. The interpretation of data and provision of information to the medical and general communities are important functions of public health agencies.


1986 ◽  
Vol 24 (23) ◽  
pp. 91-92

Although whooping cough no longer carries a high mortality, symptoms may persist for several months so that both the child and its family suffer weeks of anxiety and disturbed sleep.1 The prevalence and severity of the disease have declined since the turn of the century. Publicity about the adverse effects of whooping cough vaccination steeply reduced the uptake of immunisation in England and Wales - from 78% in 1971 to 37% in 1974.2 The subsequent epidemics of whooping cough in 1977–79 and 1982–83 were the largest since vaccination began. The epidemic which started in September 1985 could well be of similar magnitude. The uptake of immunisation has now somewhat improved and is currently about 65% (information from Communicable Disease Surveillance Centre). This article discusses whether antibiotics can help in whooping cough, either in treatment of the illness or preventing its spread.


Sign in / Sign up

Export Citation Format

Share Document